DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL TO TEST THE EFFICACY, SAFETY AND TOLERABILITY OF LITHIUM IN MULTIPLE SYSTEM ATROPHY - Lithium in MSA

• Conditions: Muliple system atrophy; MedDRA version: 9.1Level: HLTClassification code 10008028

• Registration Number: EUCTR2009-016377-15-IT
• Lead Sponsor: IVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-10-26
• Last Update Posted: 3 April 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Clinical diagnosis of probable MSA, age >18 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Heart, liver or renal disease, thyroid dysfunction, treatment with not allowed drugs, acute disease that might interfere with the study, pregnancy and/or breastfeading

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified